Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Lien Spans, Thomas Van den Broeck, Elien Smeets, Stefan Prekovic, Bernard Thienpont, Diether Lambrechts, R. Jeffrey Karnes, Nicholas Erho, Mohammed Alshalalfa, Elai Davicioni, Christine Helsen, Thomas Gevaert, Lorenzo Tosco, Karin Haustermans, Evelyne Lerut, Steven Joniau, Frank Claessens
Published Mar 21, 2016 · Vol. 7, No. 17 · pp. 24326-24338
Amit Dipak Amin, Lingxiao Li, Soumya S. Rajan, Vijay Gokhale, Matthew J. Groysman, Praechompoo Pongtornpipat, Edgar O. Tapia, Mengdie Wang, Jonathan H. Schatz
Published Mar 18, 2016 · Vol. 7, No. 17 · pp. 23715-23729
Roberta Montalbano, Birgit Honrath, Thaddeus Till Wissniowski, Moritz Elxnat, Silvia Roth, Matthias Ocker, Karl Quint, Yuri Churin, Martin Roederfeld, Dirk Schroeder, Dieter Glebe, Elke Roeb, Pietro Di Fazio
Published Mar 7, 2016 · Vol. 7, No. 15 · pp. 20312-20323